Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 318,272 shares at $154.78 ($50.6M) on 2021-01-25, disclosed to the SEC on 2021-01-26.
Open-market sale of $50.6M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.79 | 7,642 | $1.2M | 2.4% |
| 2 | $158.79 | 7,642 | $1.2M | 2.4% |
| 3 | $159.94 | 91,469 | $14.6M | 28.9% |
| 4 | $159.94 | 91,469 | $14.6M | 28.9% |
| 5 | $160.89 | 1,159 | $186K | 0.4% |
| 6 | $160.89 | 1,159 |
| $186K |
| 0.4% |
| 7 | $161.84 | 1,156 | $187K | 0.4% |
| 8 | $161.84 | 1,156 | $187K | 0.4% |
| 9 | $162.73 | 649 | $106K | 0.2% |
| 10 | $162.73 | 649 | $106K | 0.2% |
| 11 | $153.29 | 700 | $107K | 0.2% |
| 12 | $154.78 | 7,718 | $1.2M | 2.4% |
| 13 | $154.78 | 7,718 | $1.2M | 2.4% |
| 14 | $155.55 | 13,689 | $2.1M | 4.2% |
| 15 | $155.55 | 13,689 | $2.1M | 4.2% |
| 16 | $156.75 | 15,887 | $2.5M | 4.9% |
| 17 | $156.75 | 15,887 | $2.5M | 4.9% |
| 18 | $157.28 | 4,213 | $663K | 1.3% |
| 19 | $157.28 | 4,213 | $663K | 1.3% |
| 20 | $158.46 | 1,200 | $190K | 0.4% |
| 21 | $160.02 | 4,575 | $732K | 1.4% |
| 22 | $160.02 | 4,575 | $732K | 1.4% |
| 23 | $160.70 | 9,229 | $1.5M | 2.9% |
| 24 | $160.70 | 9,229 | $1.5M | 2.9% |
| 25 | $161.68 | 1,100 | $178K | 0.4% |
| 26 | $162.83 | 500 | $81K | 0.2% |
| Total | $158.94 avg | 318,272 | $50.6M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |